Although the pro-inflammatory chemokine Ccl2 was highly activated in the LLC-derived tumor (Figure 2E), we found that the Il1rn level was increased in LLC-derived tumor tissue (~four-fold) and its corresponding TILs (~50-fold) when they were compared to LLC cell line (Supplementary Figure S1D, left panel). The gene discussed is CCL2; the disease is neoplasm.